Clinical Trials Directory

Trials / Unknown

UnknownNCT02409407

Misoprostol Before Hysteroscopy in Infertile Cases

Effectiveness of Oral Versus Vaginal Misoprostol Before Office Hyteroscopy in Infertile Patients

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
120 (estimated)
Sponsor
Kasr El Aini Hospital · Academic / Other
Sex
Female
Age
20 Years – 40 Years
Healthy volunteers
Accepted

Summary

The role of hysteroscopy in infertility investigation is to detect possible intrauterine changes that could interfere with implantation or growth or both of the conceptus, with the invention of miniature hysteroscope, it is possible to perform hysteroscopy in an office setting (Outpatient hysteroscopy; OH), for diagnostic and certain therapeutic intervention. It is currently acknowledged as the 'gold standard' investigation of the intrauterine abnormalities. Cervical priming prior to diagnostic hysteroscopy softens the cervix and lessens the force needed for dilation, thereby potentially reducing the probability of procedural complication such as uterine perforation, cervical laceration, failure to dilate, and creation of a false track that can occur during cervical entry. Misoprostol is a prostaglandin El analogue, that can be administered either orally or vaginally, that can cause cervical ripening by inducing collagenolytic activity and synthesis of proteoglycans.

Conditions

Interventions

TypeNameDescription
DRUGMisoprostol , Prostaglandins E1 analogue

Timeline

Start date
2015-04-01
Primary completion
2016-04-01
Completion
2016-05-01
First posted
2015-04-06
Last updated
2015-04-06

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT02409407. Inclusion in this directory is not an endorsement.

Misoprostol Before Hysteroscopy in Infertile Cases (NCT02409407) · Clinical Trials Directory